(21) Application number 2023-849 |
(86) PCT application number US2015056686 |
(22) Filing date 26.04.2023 |
Date of the first authorization in the CZ 22.11.2022 |
Date of the first authorization in the ECC 25.08.2022 |
Number of the first authorization in the CZ 27/341/21-C |
Number of the first authorization in the EEC 141371 |
Country of the first authorization in the EEC Austria |
Product indication CS: Duodopa SC - foslevodopa/foskarbidopa |
Product type léčivý přípravek |
(71/73) Applicant/Holder AbbVie Inc., North Waukegan Road 1, North Chicago, Illinois, United States of America |
Representative JUDr. Petra Sauvage de Brantes, advokátka, Korunní 810/104, 101 00 Praha 10, Vinohrady, Czech Republic |
(40) Publication date 17.05.2023 |
Status Application filed Download xml with status |
Type SPC – forein application |
application for a certificate filed
application for a certificate published
Authorized person / Location: Ing. Miroslav Marek, CSc. / Ing. Miroslav Marek, CSc. | ||||||||
Item number | Registration date | Date of dispatch | Item name | Date of attending the request | Effective date | Fee paid | Date of payment | Official Journal Number |
AKTUALIZACE ÚDAJŮ O SUBJEKTU DLE ISZR | ||||||||
2 | PUBLIKACE ŽÁDOSTI O UDĚLENÍ DODATKOVÉHO OSVĚDČENÍ | 2023/20 published: 17.05.2023 | ||||||
1 | 26.04.2023 | žádost o udělení dodatkového osvědčení | Yes | 27.04.2023 |
2023/20 published: 17.05.2023 - PUBLIKACE ŽÁDOSTI O UDĚLENÍ DODATKOVÉHO OSVĚDČENÍ |
Parent documents: CZ/EP 3209302 |